Exabis Library
Welcome to the e-CCO Library!
OP01: Sequencing-based gene network analysis reveals a profound role for ferroptosis key gene GPX4 in post-operative endoscopic recurrence in Crohn’s disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
OP01: Withdrawal of infliximab or anti-metabolite therapy in Crohn’s Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP02 Impact of therapeutic strategies on intestinal resection rate in paediatric inflammatory bowel diseases: A population-based cohort study over a 24-year period (1988–2011)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP020: Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s disease: interim analysis from the Phase 2 FITZROY study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP020: Recent anti-TNF exposure predicts lower vedolizumab trough concentrations in patients with Crohn Disease
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:33 PM by ECCO Administrator
1
OP020: Recent anti-TNF exposure predicts lower vedolizumab trough concentrations in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP020: The clinical determinants affect gut microbial profile of inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP021: Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP021: Efficacy and safety of oral tofacitinib for maintenance therapy in patients with moderate-to-severe Crohn’s disease: results of a Phase 2b randomised placebo-controlled trial
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP021: Hyperbaric oxygen therapy is safe and effective for hospitalised Ulcerative Colitis patients suffering from moderate- severe flares: A multi-center, randomised, double-blind, sham- controlled trial
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:31 PM by ECCO Administrator
1
OP021: Hyperbaric oxygen therapy is safe and effective for hospitalized ulcerative colitis patients suffering from moderate-severe flares: a multi-center, randomized, double-blind, sham-controlled trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP022: Efficacy and safety of oral tofacitinib for induction therapy in patients with moderate-to-severe Crohn’s disease: results of a Phase 2b randomised placebo-controlled trial
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP022: Proximity extension assay based proteins show immune cell specificity and can diagnose and predict outcomes in Inflammatory Bowel Diseases: IBD Character study
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:30 PM by ECCO Administrator
1
OP022: Proximity extension assay based proteins show immune cell specificity and can diagnose and predict outcomes in inflammatory bowel diseases: IBD Character study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP022: Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: data from the CELEST study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP022: Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: Data from the CELEST study
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP023: A phase 3b open-label multicentre study (VERSIFY) of the efficacy of vedolizumab on endoscopic healing in moderately to severely active Crohn’s disease (CD)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP023: A phase 3b open-label multicentre study (VERSIFY) of the efficacy of vedolizumab on endoscopic healing in Moderately to Severely active Crohn’s Disease (CD)
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP023: Comparison between newly developed narrow band imaging and panchromoendoscopy for surveillance colonoscopy in patients with ulcerative colitis: a prospective multicentre randomised controlled trial, navigator study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP023: Maintenance of clinical effect in patients with moderate- to-severe Crohn’s Disease treated with filgotinib, a selective JAK1 inhibitor: Exploratory 20-week data analysis of the Phase 2 FITZROY study
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:28 PM by ECCO Administrator
1